Infusion is a drug delivery system, in which medicines are administered into the circulatory system of the patient through intravenous, intrathecal, subcutaneous, or intra-osseous route. If multiple medicines need to be administered simultaneously, infusion manifold is used. Infusion manifold is a medical device that allows the administration of several medications simultaneously through infusion. Manifold is a rigid IV component with multiple ports, which facilitates the joining of multiple IV components. A manifold has several inlets and a single outlet. Different medicines are supplied through multiple inlets. A mixing chamber is provided between valve inlets and the outlet, where all medicines are mixed together. The outlet is connected to the patient with catheter so as to administer mixed medicines. Due to easy structure of infusion manifolds, their use reduces the risk of hospital-acquired infections. Manifolds are ideal for anesthesiology, oncology and critical care applications, wherein simultaneous delivery of fluids is important.
With new developments, recent infusion manifolds are connected with infusion pumps that deliver constant and accurate doses. AutoTransducer is an infusion manifold manufactured by ACE Medical is integrated with convenient sensors. It is useful for pressure-sensing during clinically invasive procedures, which allows pressure-monitoring without signal damping. Infusion manifolds come with color coding to inlets, labeling such as flow directions, and transparent material of manifolds to reduce errors.
The market for infusion manifolds is likely to be fueled during the forecast period by rise in the number of patients of cancer, congestive heart failure, Crohn's disease, hemophilia, immune deficiencies, multiple sclerosis, and rheumatoid arthritis. In case of these disease, multiple infusions are required simultaneously. The increased use of combination therapies is projected to propel the demand for infusion manifolds in the near future. Factors driving the demand for infusion manifolds include their ease of use in terms of technology, efficient drug delivery to trauma and intensive care patients, and improving risk management.
The global infusion manifolds market has been segmented based on product, application, end–user, and geography. In terms of product, the infusion manifolds market has been classified into 2 gang, 3 gang, 4 gang, 5 gang, and others. In terms of application, the market has been divided into 3 way and 4 way. Based on end–user, the infusion manifolds market can be segregated into hospitals, clinics, and others. Chemotherapy patients frequently require multiple IV infusions. Manifolds are required in various departments of a hospital such as accident & emergency department, intensive care unit, anesthesia department, and ambulance services. The clinics segment has been sub-divided into private medical practitioners and independent treatment centers. The others segment comprises home infusion therapy providers.
Geographically, the global infusion manifolds market has been divided into North America, Europe, China, Japan, Southeast Asia, and Rest of World. North America is expected to hold a leading share of the global market during the forecast period, due to availability of improved infusion and infusion-related technologies in the region. Asia Pacific is expected to offer growth opportunities to leading players operating in the market during the forecast period, due to rapid advancements in health care infrastructure and rising presence of major players in the region.
Some of the major companies operating in the global infusion manifolds market are B. Braun Melsungen AG, ACE Medical, Smiths Medical, Asept Inmed, Bicakcilar, Merit Medical Systems, Perouse Medical, Sarstedt, BrosMed Medical, Scitech Medical, ICU Medical, Quest Medical, and CODAN.
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.